U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. KEBILIDI
  1. Vaccines, Blood & Biologics

STN: 125722
Proper Name: eladocagene exuparvovec-tneq
Tradename: KEBILIDI
Manufacturer: PTC Therapeutics
Indication:

  • For the treatment of adult and pediatric patients with aromatic L amino acid decarboxylase (AADC) deficiency.

Product Information

Supporting Documents

 

Back to Top